Bertha L Rodriguez

6PUBLICATIONS
78CO-AUTHORS
Molecular targetsPredictive and prognostic markersRehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 25, 2026
Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.

Natalie K Horvat, Myritney Saint-Cloud, Raihaanah Bint Abdullah Muslim

|Aug 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.

C Allison Stewart, Lixia Diao, Yuanxin Xi

|Apr 22, 2024
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors.

Bertha L Rodriguez, Jiawei Huang, Laura Gibson

|May 31, 2023
ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis.

Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian

|Jun 19, 2021
p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi.

Xiaochao Tan, Priyam Banerjee, Lei Shi

|Jan 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma.

Xiaochao Tan, Priyam Banerjee, Edward A Pham

Pageof 1